Neuroleptic withdrawal in schizophrenic patients. A review of the literature

Arch Gen Psychiatry. 1995 Mar;52(3):173-88. doi: 10.1001/archpsyc.1995.03950150005001.
No abstract available

Publication types

  • Meta-Analysis
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Acute Disease
  • Adolescent
  • Adult
  • Age Factors
  • Aged
  • Antipsychotic Agents / administration & dosage
  • Antipsychotic Agents / adverse effects*
  • Antipsychotic Agents / therapeutic use
  • Clinical Trials as Topic
  • Double-Blind Method
  • Drug Administration Schedule
  • Dyskinesia, Drug-Induced / etiology
  • Dyskinesia, Drug-Induced / prevention & control
  • Female
  • Follow-Up Studies
  • Hospitalization
  • Humans
  • Length of Stay
  • Male
  • Middle Aged
  • Placebos
  • Recurrence
  • Regression Analysis
  • Schizophrenia / chemically induced
  • Schizophrenia / drug therapy*
  • Substance Withdrawal Syndrome / etiology*
  • Substance Withdrawal Syndrome / prevention & control

Substances

  • Antipsychotic Agents
  • Placebos